MLchartDataset catalogue

B43-Genistein immunoconjugate

Term · Oncology and biomedicine · MLC-T-ONC-011858

An immunoconjugate comprised of an anti-CD19 monoclonal antibody conjugated with Genistein selectively targeting B-lineage progenitor cells and inhibiting protein tyrosine kinase, causing apoptosis.

Table 1. Record
IdentifierMLC-T-ONC-011858
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-011858",
  "term": "B43-Genistein immunoconjugate",
  "field": "Oncology and biomedicine",
  "definition": "An immunoconjugate comprised of an anti-CD19 monoclonal antibody conjugated with Genistein selectively targeting B-lineage progenitor cells and inhibiting protein tyrosine kinase, causing apoptosis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/b43-genistein-immunoconjugate/"
}

Record 3,240 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.